Sequencing the HLA region can provide critical insight into immune disorders. Achieving high-resolution human leukocyte antigen (HLA) typing results with conventional methods requires multiple assays, systems, and analysis programs. HLA typing by next-generation sequencing (NGS) generates unambiguous, phase-resolved HLA typing results using a single assay, system, and analysis program.
Join the Illumina HLA team in an engaging 3-day, hands-on training workshop to explore how NGS is delivering accuracy and efficiency to HLA typing. Attendees are eligible to receive ABHI continuing education credit (CEC).Learn More
The TruSight HLA Sequencing Panel v2 produces high-resolution typing of 11 HLA loci. Our comprehensive sample-to-report solution for HLA typing includes reagents and software optimized for HLA analysis. A simplified workflow enables turnaround time of less than 48 hours and increased efficiency with less than 4.5 hours of hands-on time.
Sequencing HLA genes has been notoriously difficult due to high levels of sequence homology, dense variability, and poor characterization of the thousands of HLA alleles in the population. Highly accurate and robust Illumina sequencing by synthesis (SBS) chemistry is the most successful and widely adopted NGS technology worldwide.* Learn how this technology is becoming the platform of choice for HLA sequencing.Learn More